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LIST OF ABBREVIATIONS 
 
BSI – British Standards Institute 
CENF – Cellulose Nanofibers 
CNF – Carbon Nanofibers 
CNTs – Carbon Nanotubes 
CSA – Coordination Support Action (an EU funding instrument) 
CTTM - Closer-to-the-Market-Roadmap  
ECHA – European Chemicals Agency  
EMA – European Medicines Agency 
EPA – Environment Protection Agency 
ETUC – European Trade Union Confederation 
FP6 – Framework Programme 6 of the European Commission (2002-2006) 
FP7 – Framework Programme 7 of the European Commission (2007-2013) 
H2020 – Horizon2020 – the EU funding mechanism (2014-2020) 
HCA - Health Care Assistant Program 
IARC – International Agency for Research on Cancer 
IFA/DGUV - Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung 
KPIs - Key Performance Indicators 
LEV - Local Exhaust Ventilation 
MNMs – manufactured nanomaterials 
NEP – Nano-enabled product 
NGOs – Non-governmental Organisations 
NIOSH – National Institute for Occupational Safety & Health 
NMs - nanomaterials 
NRVs – Nano Reference Values  
NSC – NanoSafety Cluster 
MWCNTs – Multi-walled Carbon Nanotubes 
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NEDO - New Energy and Industrial Technology Development Organization 
OECD – Organisation for Economic Cooperation and Development   
OELs - Occupational Exposure Limits 
OSH - Occupational Safety and Health 
OHSMS - Occupational Health and Safety Management Systems 
PPE – Personal Protection Equipment 
QSAR – Quantitative structure activity relationship 
REACH – Registration, Evaluation and Authorisation of Chemicals 
RIVM - National Institute for Public Health and the Environment 
RMM - risk management measures  
RPE - respiratory protective equipment  
SCOEL - Scientific Committee on Occupational Exposure Limits 
SbD - Safer by Design approach 
SCCS – Scientific Committee on Consumer Safety 
SDS - safety data sheets 
SME – small or medium enterprise 
SPE - skin protective equipment 
TDI - Tolerable daily intake  
TRL´s - Technology Readiness Levels 
VHTS - Virtual High Throughput Screening 
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GLOSSARY OF KEY TERMS USED IN THE REPORT 
 
 
Nanomaterial – definition: “material with any external dimension in the nanoscale or 
having internal structure or surface structure in the nanoscale”; in this document, the 
term nanomaterial is restricted to manufactured (i.e.; nanomaterial intentionally produced 
to have selected properties or composition) and/or engineered nanomaterials. 
Source: ISO/TS 80004-1:2015; 
 
Nano-enabled [product] – definition: “exhibiting function or performance only possible 
with nanotechnology”  
Source: ISO/TS 80004-1:2015 
 
[Market] implementation – “the act of putting a plan [nanotechnologic developments; 
nano-enabled products; etc.] into action [on the market; to customers, consumers, end-
users, etc.] or of starting to use something”   
Source: http://dictionary.cambridge.org/dictionary/english/implementation  
 
Safe by Design approach – “Safe by design is a concept and movement that encourages 
construction or product designers to "design out" health and safety risks during design 
development. The concept supports the view that along with quality, programme and 
cost; safety is determined during the design stage.“ 
Source: https://en.wikipedia.org/wiki/Safety_by_design  
 
 
 
For several definitions of terms used in the CTTM, please see the ISO Vocabulary 
“ISO/TS 80004-1:2015”: 
http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=68058&
commid=381983 
One can also use the ISO Online Browsing Platform which gives access to all ISO 
definitions. https://www.iso.org/obp/ui/ 
  
  
CTTM_NSC_Roadmap_final_for_NSC          5 
LIST OF ABBREVIATIONS ............................................................................................. 2 
GLOSSARY OF KEY TERMS USED IN THE REPORT................................................. 4 
EXECUTIVE SUMMARY ................................................................................................. 6 
RECOMMENDATIONS .................................................................................................... 8 
1. INTRODUCTION: .................................................................................................... 10 
1.1. NanoSafety Cluster - First layer - Basic scientific knowledge ........................ 10 
1.2. NanoSafety Cluster - Second layer - Research to support regulation ............. 10 
1.3. NanoSafety Cluster - Third layer - Nanotechnology Market .......................... 11 
2. NANOSAFETY CLUSTER - THIRD LAYER - NANOTECHNOLOGY 
MARKET .................................................................................................................. 12 
2.1. Setting the framework ..................................................................................... 12 
2.2. Scope ............................................................................................................... 12 
2.3. Organisation/Inventory .................................................................................... 23 
2.4. International cooperation ................................................................................. 26 
2.5. Current bottle-necks (hindering large scale access to the market of 
MNMs) ............................................................................................................ 30 
2.6. Actions proposed/CTTM-future topics ........................................................... 34 
2.7. Expected outcome ........................................................................................... 39 
2.8. Impact .............................................................................................................. 41 
2.9. Timeline and next steps ................................................................................... 42 
 
 
  
  
CTTM_NSC_Roadmap_final_for_NSC          6 
Executive Summary 
 
Nano-products and nano-enabled applications need a clear and easy-to-follow human and 
environmental safety framework for the development along the innovation chain from 
initial idea to market and beyond that facilitates navigation through the complex 
regulatory and approval processes under which different product categories fall. The 
missing framework results in a lack of (i) solid data regarding roadblocks to market 
penetration of nano-enabled products as well as the absence of (ii) transparency in terms 
of which products (e.g. containing nanomaterials (NMs); nano-enabled products) are on 
the market (e.g. registries) and voluntary schemes and labelling requirements for 
cosmetics and food, which processes are used for manufacturing nano-enabled products, 
and (iii) meager inclusiveness in the dialogue (between all stakeholders) most likely exist 
as a result of the missing framework. The Closer-to-the-Market-Roadmap (abbrev. 
CTTM) aims at speeding up the progress towards market implementation of 
nanotechnologies by outlining the steps needed to develop such a framework. In its 
current form it is addressed towards policy makers, but the ultimate framework will be 
designed for use by SME and enterprise organisations. 
The CTTM identifies the key challenges to be tackled immediately and outlines a step-
by-step approach to establishing a framework to deliver of nano-enabled products to the 
market: (i) building an inclusive collaboration network, (ii) bringing together the 
scientific and entrepreneurial experts, (iii) strengthening dialogue of all stakeholders 
(inclusiveness!) and exchange to raise synergies and safe resources, (iv) implementing of 
a novel risk assessment framework supported by the regulatory initiatives and 
implemented by contract research organisations, and (v) building service provider 
platforms which function as consulting agencies assisting companies to bring their 
products towards market implementation. 
Along these actions, the respective skillset development, educational training and 
formation of job profiles and recognition certificates shall be established. The 
accompanying tasks will be to continue the dialogue (e.g. risk communication, safety 
awareness, dissemination dialogue, needs assessment, debate on key topics, consultation 
on proposed activities/solutions, etc.) with different stakeholder groups (such as e.g. 
public authorities, broad public, opinion leaders, NGO´s, etc.) with the objective to 
increase the level of information via visualization and communication, in order to address 
all the current gaps listed within the CTTM. This will enable a transparent and open 
communication process. 
Along with facilitating the market implementation of nano-products and nano-enabled 
applications, the consumers and end users of these products shall be provided with a clear 
and validated declaration regarding the use and function of NMs in products. Such 
information will show, in a balanced and standardized way the risks and benefits of the 
nano-enabled vs. the previously established products and of course addressing the unique 
new products and applications enabled by nanotechnology. This will increase 
understanding (and potentially support building trust) among stakeholders about safety 
issues, reduce the uncertainties for SMEs and enterprises about how to address the nano-
enabled products (and NMs) properly, and minimise the impact of risk and safety 
assessment processes on hampering the innovation potential. 
Following the recommendations of the EU REACH system (Article 13) and regarding 
ethical aspects, the risk assessment procedures should be performed with possible 
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reduction of living animals’ use. Whenever possible, alternative methods such as in vitro 
and in silico (computational) testing should be applied for replacing experiments with 
higher animals. Moreover, the use of computational modelling for supporting Safer-by-
Design (SbD) and High Throughput Screening (HTS) might be an interesting option for 
the innovative industry, since it enables to extend the number of considered solutions 
without increasing costs. 
The actions proposed in the CTTM will reduce the uncertainties for all stakeholders, 
increase the safety of nano-enabled products while reducing their time to market, and 
increase the market confidence in this technology and the acceptance of the safe nano-
enabled products by businesses and consumers.  
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Recommendations 
 
Market implementation shall be envisaged based on solid operational knowledge (high 
level of scientific expertise and robust accumulated datasets) about nanotechnologies’ 
impact on human health and the environment. It is recommended to build this knowledge 
via the establishment of an ongoing dialogue between science (e.g. nanosafety research), 
industry (e.g. innovators), and public bodies (e.g. regulatory authorities, panels and 
committees, policy makers, politicians, NGOs, etc.). 
An inclusive European approach, accompanied by strong global interaction and taking 
into account the high level know-how of organizations and authorities globally shall 
facilitate realisation of, and reduce barriers to achieving, the positive economic impact 
promised by nanotechnologies. This shall be reached by bundling activities in all 
European countries to maximise synergies and progress, establishing an ongoing global 
interaction and including publicly (National, European, and global) and privately funded 
initiatives into a cohesive, transparent and active hub of support for SMEs and enterprise 
regarding safe and benign nanoproducts. 
Based on current knowledge and in anticipation of future regulations, easy-to-apply 
safety thresholds together with benchmarking of skills and jobs shall be implemented and 
applied to provide the public and the industry with a clear “risk and safety framework” 
against which to assess the safety of nano-enabled products versus the benefits of their 
utilisation in specific applications along their whole product life cycle. Where applicable, 
alternative solutions should be provided and discussed in order to improve the risk-
benefit profile and enhance consumer and regulatory confidence. 
Building on the strategies for Europe 2020 and for an Innovation Union, the focus of a 
European nanosafety expertise hub must be inclusive and representative of economic 
sectors/companies as well as research organizations and academia as well as authorities, 
bundled or coordinated via member states networks. Harmonized tools and methods (best 
tools) for industry to address nanosafety issues shall be created and tested in most 
representative European sectors, and passed to contract research organisations for routine 
implementation as per safety testing of chemicals, pharmaceuticals, pesticides etc. More 
attention should be put on the development and application of computational tools. 
However, the methods should be easily applicable and the rigorous validation criteria and 
evaluation procedures for the modelling must be established for ensuring the evidence of 
high quality of the predicted results. 
For the national networks, it is expected that they bring together the national 
stakeholders, including industrial partners, and constitute a representative group of the 
member states’ community, communicating bottom-up and top-down the state-of-the-art 
(scientifically relevant and real-life-applicable) findings/improvements in the CTTM-
related work, and contributing actively to the continuous shaping of the European 
nanosafety framework and regulatory frameworks in each application area. 
All the educational, risk-management and other tools and guides listed in CTTM could 
be utilised as a blue-print for use by different sectors, and a central nanosafety centre 
could work with each of the sectoral industry associations to tailor them appropriately, 
combining the sector-specific expertise of the industry association and the nanosafety 
expertise of the European centre. 
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The CTTM-European network shall define (and continuously observe and adapt) an 
overall concept and a suitable approach to address the needs and objectives of this 
roadmap, building a hub of best-practice that facilitates rapid deployment across all 
member states, with a focus on increasing uptake of nano-technologies in the new 
member and accession states. This should be established initially by core funding from 
member states and the EU, via the establishment of an EU-wide knowledge hub. To 
ensure that accumulated knowledge and experience is not lost post the funding cycle, and 
to support ongoing developments including in other emergent technological areas, strong 
two-way linkages with established industry organisations is required, including 
potentially leveraging funding from these for nano-specific activities in the longer run. 
For development of a nanotechnology market it can be said that in terms of addressing 
safety aspects, the nano-related industry is ahead of the curve, and one of the goals of 
CTTM is that the activities in the nano-field shall be supported by dedicated funding of 
nanosafety research (interdisciplinarity of research) to support responsible research and 
innovation in the nanotechnology field. 
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1. INTRODUCTION: 
1.1. NanoSafety Cluster - First layer - Basic scientific knowledge 
The rapid initial translation and introduction of nanotechnology-based products into the 
market has brought the question of its long-term safety and the resulting risk 
management measures. This, and the current lack of practice to transfer nanotechnology 
risks to the insurance sector, has led to a slowing down of translation / commercialisation 
activities, uncertainty regarding legal liabilities and insurance aspects, slowed venture 
capital investment, and a significant change in attitude by companies producing nano-
enabled products with regard to their claims and publicity regarding nanotechnologies. 
To address these concerns, considerable effort has been undertaken by FP6 and FP7 
projects to answer basic scientific and technical questions and will continue under 
H2020. Updates from these projects are provided in the annual NanoSafety cluster 
compendium1, and research needs to 2025 have been outlined in the research roadmap 
launched by the NanoSafety cluster2. 
1.2. NanoSafety Cluster - Second layer - Research to support regulation 
A second layer of activity consists of supporting the regulatory aspects including 
validation of methods and supporting translation of scientific development into 
regulatory practice. Examples of regulatory support activities include provision of the 
technology, skills and conventions necessary for science based implementation of 
existing rules and consistent development of new ones. This effort takes two main 
directions. 
1.2.1. Enabling regulation of existing NMs by competent authorities 
based on robust data, sound scientific understanding, and new 
tools/assays demonstrated to be suitable for use with NMs 
which can be used to improve regulatory decision-making. 
1.2.2. To reduce the potential for health risks along the product life 
cycle by developing and stimulating safe-by-design and 
benign-by-design concepts. 
In the short term these objectives are covered by three projects. 
• NANoREG, which is a 50M€ project funded by the FP7, the EU-member states 
and industry. It is running since March 2013. 
• The follow-up project (i.e. ‘NanoReg II’), which will address the safe-by-design 
aspects – has started in September 2015. 
• The Coordination and Support Action (CSA) entitled ‘PROSAFE - Promoting the 
Implementation of Safe(r)-by-Design started in February 2015 and will run for 
two years. 
Furthermore, technical projects are providing these three with scientific data, e.g. 
NanoMile and NanoSolutions (hazard, both 2013-2017), NanoFASE (fate, Sept. 2015-
                                                 
1
 Ref. to NanoSafetyCluster-Compendium – download: http://www.nanosafetycluster.eu/home/european-
nanosafety-cluster-compendium.html  
2
  http://www.nanosafetycluster.eu/  
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2019), GuideNano (risks, 2013-2017), SUN (risks; safe use; 2013-2017), etc. – further 
projects and details can be found on the NanoSafety cluster homepage3. 
 
In the long term regulatory research activities will be addressed as defined in the 
Roadmap regulatory research (corresp. author: Vicky Stone).4 
 
1.3. NanoSafety Cluster - Third layer - Nanotechnology Market 
Beside research and regulations, a third layer, which has received less attention in FP7, 
but is a central feature of H2020, is the market layer, which focusses on research to 
support commercialisation of nano-innovations and nano-enabled products along the 
whole value chain. The market layer is the subject of this roadmap. 
 
  
                                                 
3
  http://www.nanosafetycluster.eu/  
4
  Link to the regulatory roadmap shall be provided (not available at the moment Feb. 16th, 2016) 
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2. NANOSAFETY CLUSTER - THIRD LAYER - NANOTECHNOLOGY MARKET  
2.1. Setting the framework 
It is usual that once a technology enters the market the safety management can only be 
done thereafter. As this is true for all kinds of new technologies, to enable the safety of a 
technology is in itself a market i.e. professional services supply and demand and 
provision of contract research services to generate the data needed for regulatory 
approvals. 
Companies bring products to the market that are safe for the intended use. Over time, 
there will be assessed new uses, a.o. because we learn more about the safety in different 
circumstances. Hence, the level of safety achieved from application of any new 
technology will usually increase over time. Safety and risk are usually also put in the 
context of the benefits the new technology can offer for a society (risk-benefit analysis). 
The decision to be made in each case is "how much of today's resources ought to be 
invested for the benefits of tomorrow?" in terms of both Health and Environment. 
Each new technology application is based on regulation developed either in generic terms 
or in sector/application specific terms. Implementation of the regulation should be 
possible in non-ambiguous conditions.  
Development of any new regulation (i.e. new rules/practices) will be based on solid 
scientific knowledge and will have to be enforceable. 
Comprehensive and unambiguous information on the risk of each new technology should 
be made available and communicated to the end-user. However, for each new 
product/application combination it may be different. Three main groups should receive 
information on potential risks within the lifecycle of a NM or nano-enabled product: 
• Workers handling (or transporting) NMs and/or nano-enabled products  
• Professional users of nano-enabled products; and,  
• Consumers buying and using products containing NMs as part of a formulation 
or nano-enabled products. 
In addition, information on the risks from nanotechnologies is important to underwriters 
so that they can develop robust practices to transfer these risks from the nanotechnology 
industry to the insurance sector and thus facilitate R&D investment into new 
nanotechnology products. 
2.2. Scope 
The scope of this CTTM is to identify best practice and unfulfilled gaps in terms of 
where and how the scientific / research community, via H2020 and member state funding 
initiatives, can support the commercialization of this new technology. Such support could 
take the form of provision of the technology, skills, processes, trained personnel, and 
tools necessary for implementation of science-based nanosafety best practices in the 
industrial & commercial activities in order to facilitate sustainable and responsible 
creation of marketable products and goods, which will be successful on the market and 
bought/used by society. This effort takes three main directions, irrespective of the 
regulatory regime applicable to the specific product / application: Setting minimum 
requirements for nanosafety-related jobs, skills and/or tools. This is provided in the form 
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of a roadmap which is a plan that matches short-term and long-term goals with specific 
solutions to help meet those goals (see chapter 2.5 and 2.6). It is a plan that applies to a 
new product or process, or – in this case – to an emerging technology, nanotechnology. 
CTTM has three major uses: it helps reach a consensus about a set of needs and the 
technologies required to satisfy those needs; it provides a mechanism to help forecast 
technology developments; and it provides a framework to help plan and coordinate 
technology developments. 
 
2.2.1. Building capacity for formalisation of jobs 
• Risk monitoring 
Risk monitoring means monitoring of exposure in view of compliance with a benchmark 
level. Ideally, this benchmark level is health-based. However, only for a few NMs do 
such health-based levels exist currently. For instance NIOSH has proposed 
Recommended Exposure Limits for TiO2 and CNTs; the SCOEL committee recommends 
occupational exposure limits to the EC5, however currently NMs are not on their agenda. 
In Japan the NEDO-project has also proposed ‘limit values’ for CNTs. The situation is 
further complicated by the fact that for specific types of CNTs, e.g. Baytubes6 (Pauluhn, 
2010) or the Nanocyl MWCNTs (Ma-Hock et al., 2009) slightly different ‘Occupational 
Exposure Limits (OELs) were proposed as a result of their different properties leading to 
different degrees of health risk. Still, for most NMs such benchmark levels are currently 
lacking. Therefore non-specific benchmark levels have been proposed. BSI (UK) 
launched an initiative for ‘generic’ NM benchmark levels (BSI 2009) relevant for 
granular biopersistent NM without specific toxicity, whereas IFA/DGUV (Germany) 
adapted these values to comply with a generic threshold value of 0.1 mg/m3 for 
hazardous substances7. This was then further adapted in the Netherlands, where the 
concept of Nano Reference Values (NRVs) was accepted. So in practice such a 
benchmark level is used as a surrogate to evaluate exposure levels with respect to risk. 
However, this is possible only for granular (i.e. non fibrous) NMs without specific 
toxicity. Currently, registration of ‘nano workers’ or job titles with high probability of 
exposure to NMs is in an early stage in some EU countries, e.g. France and the 
Netherlands. Epidemiological studies are in pilot phase and therefore cannot contribute to 
an adequate risk monitoring at this stage. However, these studies should focus on early 
markers of effect rather than on clinical health outcomes. Clearly, such studies should be 
conducted using harmonised protocols to enable future data pooling in order to enhance 
the power of such studies. 
• Risk Assessment, risk characterization 
Risk is a function from hazard and exposure. The risk assessment (RA) is an established 
procedure, recognised by several regulatory agencies and international organizations 
such as ECHA, EPA, OECD and the WHO, which estimates the likelihood of adverse 
health and/or environmental effects due to exposure to chemical substances. The RA 
framework is composed of hazard and exposure assessment, risk characterization and 
uncertainty analysis. Specifically, the hazard assessment involves hazard identification 
and dose-response analysis. The hazard assessment is carried out by evaluating relevant 
                                                 
5
 http://ec.europa.eu/social/main.jsp?catId=148&langId=en&intPageId=684 
6
 No longer on the market 
7
 http://www.dguv.de/ifa/Fachinfos/Nanopartikel-am-Arbeitsplatz/Beurteilung-von-
Schutzma%C3%9Fnahmen/index-2.jsp 
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physicochemical and toxicological information from in vitro and in vivo tests to assess 
the intrinsic hazard of a substance. The dose-response analysis characterizes the 
relationship between the dose of the substance and the incidence of adverse health effects 
in the exposed population in order to establish a “safe” or “tolerable” dose (i.e. TDI). 
This generally involves the estimation of a Point of Departure (PoD) (e.g. Benchmark 
Dose or a No-observable Adverse Effect Level) based on data obtained from animal 
studies, and the extrapolation of this PoD for animals to a TDI for humans by means of 
uncertainty factors. The exposure assessment is typically based on exposure 
measurements in occupational, consumer and/or environmental settings and/or the 
estimation of exposure levels by means of models. This is always performed for one or 
more exposure scenarios (ES), which describe(s) the operational conditions in which the 
substance (on its own or in mixture or an article) is handled or used. In the risk 
characterization step, the estimated exposure levels are compared to the TDI or a 
Reference Exposure Limit (REL). If the estimated exposure exceeds the human effect 
threshold, or the REL, a conclusion can be made that the risk for the target population is 
not acceptable.  
Unfortunately, the data for a proper science based RA of nanomaterials are limited (e.g. 
biokinetic data are missing). This is why the development of methods and tools to 
generate such nano-specific data has become a dynamic area of research, which resulted 
in an array of test protocols for sample preparation, physicochemical characterization, 
and in vitro and in vivo toxicology, which have been developed in many FP6, FP7 and 
H2020 projects, including but not limited to MARINA, SUN, GuideNano, NanoMile, 
NanoDefine, NanoSolutions, NANoREG. In addition, risk categorization and control 
banding tools have been proposed, including a hazard identification tool (Hristozov et al., 
2014b), an occupational exposure prioritization tool (Hristozov et al., 2014a), the 
TEARR risk ranking tool (Grieger et al., 2015), the Swiss Precautionary Matrix (Höck et 
al., 2010), NanoRiskCat (Hansen et al., 2013), the Control Banding Tool (Paik et al., 
2008), the ANSES system (Ostiguy et al., 2010), Stoffenmanager Nano (Duuren-
Stuurman et al., 2011), and NanoSafer (Jensen et al., 2013). Moreover, Decision Support 
Systems for risk assessment and management of nanomaterials are currently being 
developed in the SUN and GuideNano projects.  
 
• Risk reduction by prevention, Risk minimization 
Risk reduction by prevention and hence reducing uncertainty8 has been indicated already 
in the context of REACH implementation. Risk minimization is usually an outcome of a 
scientific based risk assessment. Based on scientific data risks for certain types of NMs 
are calculated. This results in an understanding of “safe” or “tolerable” doses (i.e. the 
tolerable daily intake or TDI). Based on this, acceptable amounts of NMs in certain 
products can be derived. However, currently data for a proper science based risk 
assessment are limited (e.g. biokinetic data are missing). 
Risk and waste management practices currently applied to NOAA [e.g. Engineering 
Controls (fume hoods, local exhaust ventilation, enclosed glove boxes), administrative 
controls (HEPA-filtered vacuum cleaner or wet wiping methods), Personal Protective 
Equipment (respirators)] do not significantly depart from conventional safety practices 
                                                 
8
 See Schaafsma et al (2008): «REACH, non-testing approaches and the urgent need for a change in mind 
set », J.of Regulatory Toxicology and Pharmacology, DOI 10.1016/j.yrtph.2008.11.003. 
  
CTTM_NSC_Roadmap_final_for_NSC          15 
for handling chemicals. These procedures are based upon the properties of the bulk form 
or the solvent carrier and not on nano-specific characteristics.  
Only recently, Safe by Design (SbD) has become a national initiative in the US. This 
approach aims to retain the functionality of materials and products, while reducing their 
health and environmental risks. The development and implementation of SbD risk 
control strategies is a major challenge to overcome in order to ensure the sustainability of 
nanotechnologies. However, it is presently constrained by: (i) the knowledge gaps, still 
existing on nano EHS issues and (ii) the control of costs. 
Various research projects (e.g. Scaffold9, NanoMICEX10, Sanowork11, SUN12, 
Guidenano13) have attempted to overcome these challenges and provided good examples 
to demonstrate the SbD proof of concept, however, SbD has not yet been fully integrated 
into material, product and process development, despite having already achieved a high 
level of NM manufacturing development, as presented by RIVM recently within the 
NANoREG project. 
In the context of SbD, it would be highly beneficial to develop and apply in near future 
Virtual High Throughput Screening (VHTS) strategies based on computational 
modelling and simulations. In this way, it should be possible to considerate much larger 
libraries of nanoparticles containing much larger variation in the nanoparticles’ structure 
without significantly increasing the amount of experimental work. Along with this idea, 
the experimental data obtained for only few nanoparticles being representative for a 
group, can be utilized for developing models and then making predictions for the 
remaining members of the group. At the final stage, only few virtually selected “best” 
nanostructures should be tested experimentally to confirm their properties. At this 
moment, the usefulness of such tools as (Quantitative) Structure-Activity Relationships 
([Q]SAR) modelling and/or read-across for hazard (toxicity) assessment has been 
demonstrated by the six EU “modelling projects” (NanoPUZZLES14, MODERN, 
PreNanoTox, ModENPTox, MembraneNanoPart, and eNanoMapper) funded under FP7 
and working jointly within NanoSafety Cluster as well as by COST MODENA action. 
Risk awareness is an important factor that determines the attitude of workers and their 
safety behaviour as well. Education and training have been demonstrated to be 
fundamental tools to improve worker’s safety behaviour. Practical tools have been 
developed to support risk awareness e.g. NanoSmile15, however, integration of such tools 
with training programs is needed. 
NanoEIS16 CSA surveyed the skills needs of industrial and societal employers with 
regards to nanotechnologies. Furthermore, in this project it compared the needs to the 
current provision of nanotechnology education, and determined significant gaps at 
university in terms of health and safety and environmental safety provision, with 
employers requiring these skills now and in 5 years time. 
 
                                                 
9
 http://scaffold.eu-vri.eu/ 
10
 http://www.nanomicex.eu 
11
 http://www.sanowork.eu 
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 http://www.sun-fp7.eu 
13
 http://www.guidenano.eu 
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 http://www.nanopuzzles.eu 
15
 http://www.nanosmile.org/index.php?lang=en 
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 http://www.nanoeis.eu/ 
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• Risk mitigation 
Once all potential risks are identified, assessed and thoroughly evaluated, risk reduction 
strategies should be considered in a systematic approach. Essentially, there are two ways 
of mitigating or reducing the risk: hazard control through modification of NM properties 
while maintaining their original features and functionality and exposure control reducing 
the release of NM from industrial processes or consumer products or limiting the 
exposure of workers and consumers to NM by means of administrative measures and 
behavioral guidelines. It has been recommended that these risk management measures 
are applied according to an established hierarchy of control (Figure 1). Although it is 
widely agreed that traditional methods used to control exposure to particles can be 
implemented to NMs, there is a need to confirm their effectiveness against NMs20.  
 
 
Figure 1: Hierarchy of risk controls applicable to NMs. 
 
If the application of elimination and substitution techniques does not effectively mitigate 
risks below acceptable levels, engineering control measures should prevent releases or 
emission of NMs into the (workplace) air and measures that affect the transport of the 
NMs through the air to the worker or systems that prevent or reduce explosion/fire of 
very reactive NMs. If the engineering control measures does not effectively mitigate the 
risks, administrative control should cope with this by defining work practices in 
documented form. This is explicitly demanded under the ‘process control’ requirements 
of the ISO 9000 standard, which state that work shall be performed under controlled 
conditions, including use of process documentation, where lack of such documentation 
could reasonably be expected to adversely affect risk management. Such administrative 
measures are typically combined with occupational guidelines to prevent workers‘ 
behaviours that could increase their exposure to the chemicals and the associated risks. 
Unfortunately, there are still no administrative and behavioural control measures 
specifically tailored to NM, but the H2020 project caLIBRAte (H2020; webpage not yet 
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available) will perform research in this context. Personal protective equipment is 
considered the last resort with respect to risk mitigation. The empirical evidence of the 
effectiveness of control measures for conventional substances has been documented in an 
on-line library (Ecel17), however, there is currently little information on the specific 
effectiveness of the controls for NMs and it has not been inserted into a library so far. 
Risk banding tools, e.g. Stoffenmanager Nano (NL) and Nanosafer (DK) have libraries 
with information on exposure control measures, which would be the first step to extract 
‘best practices’ for handling and other processes. Similar information can be retrieved 
from on-line libraries, e.g. Good nano Guide18. 
The selection of adequate risk management measures (RMM), including Local Exhaust 
Ventilation (LEV) systems, filtration, respiratory protective equipment (RPE), skin 
protective equipment (SPE), safety goggles and protective clothing, as well as 
fire/explosion or runaway chemical reaction protection systems, plays a crucial role in 
the safe handling and use of NMs. In most cases, a combination of partly elimination, 
substitution, engineering controls, administrative controls, process safety protective 
systems and personal protective equipment (PPE) are chosen to effectively control the 
risks. Most of these exposure control methods are applicable to NMs, but their 
performance to control ENM exposure should be further evaluated under different 
exposure scenarios. This has been addressed in a growing number of European and 
international efforts, including FP7 projects such as MARINA, SUN, SANOWORK, 
Scaffold, Nanomicex and NanoSafePack, and GUIDEnano. 
To support sustainable jobs in nanotechnology, ensuring nanosafety is critical. To 
support this goal, the available but currently scattered information on risk prevention and 
control should be collated into easy accessible libraries. SUN started collecting the 
available knowledge into a Techonological Alternatives and Risk Management Measures 
(TARMM) inventory located in Ecel19, which includes information on efficiency and 
costs, but future projects should take up this initiative in a continuous commitment. 
Moreover, national and virtual (collaborating) transnational nanosafety centres, which 
function as nodes for nanosafety-researchers, should collate information on ‘best 
practices’ and, depending on national regulations, act as focal points for risk monitoring 
activities, which may include (exposure) registration and future efforts towards 
epidemiological studies. 
• Risk Communication 
Nanotechnologies are an evolving area of technological advancement and as with many 
chemicals, the hazard and risk information pertaining to these new forms of materials is 
often complex, conflicting and incomplete, yet there is still a need to adequately convey 
such information to stakeholders (industry, regulators, NGOs, the public); ECHA is 
working on that, and so does the NANoREG-project20. Risk communication involves 
providing information on levels of health and environmental risks, their significance and 
their management (e.g. NanoDialog - Germany21). 
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• Risk transfer  
One considerable obstacle that hinders investment in nanotechnologies and their 
successful commercialisation is the lack of practice to transfer their risks to the insurance 
sector. This issue stems from the ambiguity surrounding the safety of nanotechnologies, 
which prevents the underwriting community from understanding the risks and adopting 
legal-organisational-commercial risk transfer mechanisms such as captives, self-
insurance, and risk sharing). The lack of the practice to disperse risk through access to 
insurance markets affects especially the SMEs, because due to their size and access to 
capital, they are vulnerable to changes in risk perception. Despite the clear interest of the 
insurance industry to engage with the science and regulatory communities in developing 
underwriting protocols for nanotechnology risks, it currently lacks the tools to do so. The 
development of such decision making tools and robust risk transfer practices is essential 
and should take into account the existing regulatory, legal and actuarial practices. This is 
one of the aims of the H2020 project caLIBRAte. 
 
2.2.2. Building capacity for formalisation of skills 
• Standardisation 
Standardisation is one of the key elements in research and development to provide 
reproducible results. ISO defines a standard document as “document that provides 
requirements, specifications, guidelines or characteristics that can be used consistently to 
ensure that materials, products, processes and services are fit for their purpose”. This 
standardisation process leads to an improved and consensus development of new 
technologies to be used safely for economy and social purpose22. One of the biggest 
problems in standardisation of NM test methods (characterisation and toxicity) is missing 
standardisation guidelines and protocols to be followed by all means as well as missing 
reference materials, however, this is work underway under the frame of OECD-
sponsorship program and in ISO/TC 229 as well as by JRC towards a repository. In 
addition, OECD is responsible for harmonization of toxicity test methods. A pre-requisite 
is method validation, typically achieved by blinded study design to test a larger set of 
chemicals with known outcome. Beforehand typically the method is defined by round 
robin exercises. So far only a limited amount of round robins have been performed for 
nano-testing methods and no specific method validation has started.  
Furthermore, due to the different properties of engineered NMs they can interfere with 
available test systems for hazard assessment, which were established for their bulk form 
or they may have different matrix interactions in analytics, which hampers quantification. 
The same problem is visible for computational toxicity predictions, where the models are 
developed and – what is more important – are validated according to different, non-
standardised protocols. At this point it is also necessary to start with standardisation of 
characterisation methods before focusing on standardizing toxicity screening 
methodologies for NMs to evaluate properties, morphologies, chemical stability and 
biokinetics. Furthermore a characterisation in relevant media to exploit changes in 
behaviour when getting in contact with different media (e.g. agglomeration, aggregation, 
bundling, etc.) has to be performed. Despite the fact that all scientist agree that the 
characterization inside the test medium is important, no generally accepted guidelines 
exist. After the characterisation of NMs they might be grouped (not yet in place) 
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 ISO. (2013). International Organization for Standardization. Retrieved July 31, 2013, from www.iso.org 
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according to their behaviour shown and application used (human and environmental 
exposure). Following a proposed case-by-case approach exposure can be estimated and 
scenarios deducted to focus in the next step on adaption and/or establishment of 
existing/new toxicity methods23. In line with this, the standardisation skills may include 
knowledge about materials, products, processes and technologies, models, experience in 
preparing guidelines and SOP’s, and shall be included in education actions. 
• Education 
The need for education has featured prominently in European policy texts such as the 
European Commission’s Strategy for Nanotechnology of 200424 and its Nanosciences 
and Nanotechnologies Action Plan of 2005,25 which aims to ‘Promote networking and 
disseminate ‘best practice’ for education and training in N&N.’ Along with similar 
policy mandates for education on European member states and in other parts of the globe, 
this has resulted in a wide range of nanotechnology education activities over the last 
decade26. Also, NanoEIS27 identified that educating for the general public is best 
achieved by including nano topics in primary and secondary education as that way it 
filters into homes as families discuss what children learned at school. Combined with a 
plethora of activities on national and regional levels, the question for nanotechnology 
education is not what education materials to develop, but how to make best use of the 
available material. There is already a Teacher’s net28, which has a mandate to develop 
teaching materials, and will translate them (free of charge) to any EU language upon 
request from just 3 teachers! This is not sufficiently widely known, nor utilised, so again, 
compilation and communication of existing resources is key. To gain value added for 
society, these skills may be build up in schools by involvement of N&N already in 
secondary school, as well as in basic lectures of relevant scientific studies. Ideally, all 
chemistry and materials science programmes in the EU should have at least one module 
covering safety and environmental assessment aspects, such that those developing 
materials have at least a basic understanding of the consequences of their developments. 
This was also called for with respect to Green Chemistry, as a means of embedding the 
concept into common experience.29 
Ongoing research projects continuously push the edge of knowledge in the nanosafety 
research field, and it is important to disseminate this evolving frontier to educate young 
scholars and professionals across the public and private sectors. Training courses and 
workshops are being organised in most NSC projects, trying to provide an understanding 
of their scientific outputs and the achievements. Although not all NSC projects have 
specific work packages dedicated to education, most of them have budgets to perform 
training to ensure a high level of skills and consistency within the consortiums and to 
transfer the new knowledge for education of both young and experienced professionals 
from academia, industry, regulatory agencies etc.  
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 Geys, J., Nemery, B., & Hoet, P. H. M. (2010). Assay conditions can influence the outcome of 
cytotoxicity tests of nanomaterials: better assay characterization is needed to compare studies. 
Toxicology in Vitro : An International Journal Published in Association with BIBRA, 24(2), 620–9. 
doi:10.1016/j.tiv.2009.10.007 
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 European Commission (2004). Towards a European Strategy for Nanotechnology. COM(2004) 338  
http://ec.europa.eu/nanotechnology/pdf/nano_com_en.pdf    
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 European Commission (2005). Nanosciences and nanotechnologies: An action plan for Europe 2005-
2009. COM (2005) 243 
http://ec.europa.eu/research/industrial_technologies/pdf/nano_action_plan_en.pdf   
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Although many nanosafety training schools and workshops are taking place in projects 
each year, until now there has been no coordination of these events on the NSC level. 
Therefore, the SUN project developed and coordinates a NSC WG on Training. This WG 
aims to support nanosafety education through aligning the training agendas of the NSC 
projects to achieve the following objectives: i) Perform trainings where partners 
collaborate across the boundaries of projects and disciplines; ii) Ensure a high level of 
skills and consistency within the projects; iii) Transfer the knowledge generated in the 
projects to external stakeholders; iv) Enhance training offerings through collaboration 
and sharing of experience. 
• Professional training and certification 
Like for any other compounds, companies handling NMs must ensure a safe workplace 
and must be able to confirm that this objective is achieved. This is particularly difficult in 
the current context of  
• knowledge gaps on hazards from and exposure to NMs, and on the efficiency of 
personal prevention and precaution measures and equipment towards NMs30. 
• frequent lack of detailed information about the product composition and their 
possible nano-specific health and safety issues and frequent loss of the information 
available from the raw material manufacturer while stepping down the value chain31 
32
. 
Research projects have produced valuable information for Occupational Safety and 
Health (OSH) practices regarding NMs. There is the need for organizing and bringing 
this information to the industry in the form of science-based training and certification on 
nanosafety at the workplace, especially to SMEs or to OSH service providers (and also to 
many small research teams not familiar with industry’s OSH procedures. 
This work has already been started, for example: 
• The French research and service institutes INERIS and CEA have developed a 
training and certification course for nanosafety at work33. More than 200 trainees 
from industry have received the training and, after successfully completing the exam, 
a certificate. The offer includes an on-site certification of the workplace. 
Developments are still welcome, such as on Personal Protection Equipment. 
• The FP7 project Scaffold34, developed and implemented training modules for the 
construction sector, along with a risk management model. However, one of the main 
results of the project, the Toolkit, works in a specific mode of operation only, 
specifically designed for training reasons. This mode allows access to an extensive 
library of knowledge (processes, hazards, toxicology, devices and methods of 
measuring exposure, exposure databases, best practices, protective measures, etc.) 
and a set of tools for managing nano-risks in construction (risk assessment, KPIs, 
OHSMS diagnosis, implementation, and audit, etc).  
• FP7 project NanoValid35 has produced a set of documents called “Nano to Go!”: 
Nano to Go!36 is a practically oriented guidance on safe handling of nanomaterials 
                                                 
30
 http://www.nanosafetycluster.eu 
31
 FIEC et al., 2009: “Nanotechnology in the European Construction Industry ‐State of the art 2009 ‐ 
Executive Summary”,  
32
 EU-OSHA, 2012: “European Risk Observatory – Literature Review”, https://osha.europa.eu/en/tools-
and-publications/publications/literature_reviews/workplace_exposure_to_nanoparticles 
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(NMs) and other innovative materials at the workplace. It was developed within the 
NanoValid project by the German Federal Institute for Occupational health (BAuA). 
• Some European trade unions or similar bodies (notably ETUC member organisations, 
such as national occupational health institutes) have already produced corresponding 
information destined for workers.3738  
There is the need to consolidate and develop these first initiatives so as to make available 
to industry and other stakeholders concerned a European-wide, up-to-date, science-based, 
complete training and certification system for nanosafety in the workplace. However, 
education is not only needed with respect to occupational safety.  
• The German Federal Institute for Risk Assessment (BfR) has developed in 
cooperation with the European Infrastructure project QualityNano39 a training event 
specifically dedicated for risk assessors with a focus on consumer safety, which took 
into account specific issues for material characterization and toxicity testing. It 
addition current regulation (e.g. REACh, cosmetics, novel food and biocides 
regulation) was explained and discussed.  
• EMA has developed training events specifically dedicated to understand risk 
assessment for nano drugs. 
An overview of different types of trainings, especially for scientists and laboratories, can 
be found on the QualityNano webpage40, although this is not being updated any longer. 
The NanoSafety Cluster website has a calendar of upcoming events, including training 
provided by FP7 and H2020 projects, and the new Training sub-group is developing an 
updated and projected to the next several years roadmap of the training planned in FP7 
and H2020 projects to allow oversight, consolidation of offers and gap analysis. 
2.2.3. Building reliable tools for nanosafety at work 
• Risk management model 
As for OSH training and certification, there is a need for the development, testing, 
validation and dissemination of holistic, consistent and cost effective RMM to manage 
occupational exposure to NMs in the different industrial sectors. These RMMs should be 
based on state-of-the-art safety management systems (OHSAS 18001 + ISO 31000) and 
should organize the different tools and data available for OSH consultants and managers, 
including: 
• Tools for analysis of occupational risks along the life cycle of NMs and nano-
enabled products 
• Valid or newly proposed globally harmonized Occupational Exposure Limits 
(OELs), as well as reactivity parameters (e.g. explosion & flammability limits)  
• Exposure measurement protocols 
• Control banding tools 
• Risk management diagnosis, implementation and audit 
• Etc,.. 
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The first sectorial-specific initiatives, such as Scaffold for the construction sector and 
NanoMicex for paints and pigments should be consolidated and developed at a 
European-wide, multi-sectorial scale. 
Project Scaffold produced a “Library of Solutions for Risk Management” including a 
specific handbook, four quick guides (risk prevention, risk assessment, risk protection 
and risk management) and a Toolkit (software), based on OHSAS 18001 + ISO 31000, to 
facilitate the diagnosis, implementation and audit of nano-risk management in large 
companies and SMEs, in construction. Recently, the CEN/TC 352 "Nanotechnologies" 
committee decided to accept a New Work Item (NWI) proposal relating to CEN/TS 
"Manufactured nanomaterials (MNMs) in the construction industry: Guidelines for 
occupational risk management”41, lead by partners of the Scaffold project.  
• Safety Data Sheets 
The main routes of hazard and risk communication are pictograms, signal words (e.g. 
“danger”, “warning”), hazard and risk phrases and the provision of information via safety 
data sheets (SDS). The transmission of the nanosafety information through the Safety 
Data Sheets is generally very incomplete, and information provided is often for the bulk 
form. The result is a frequent lack of detailed information about the product composition 
and their possible nano-specific health and safety issues, and frequent loss of the 
information available from the raw material manufacturer while stepping down the user 
chain (FIEC et al., 2009; EU-OSHA, 2012).  
Transcription processes to support the translation of scientific knowledge into the SDS 
have to be established and implemented, and should be done at the EU-level. The 
development of high quality SDS is therefore a fundamental element underpinning the 
safe and responsible development of NMs and nano-enabled products. Some efforts in 
this direction have already been made, such as the Swiss effort, and could be built upon. 
Indeed, guidelines are now available in Switzerland which may help in the preparation of 
SDS for NMs and nano-containing products and better support the appropriate 
communication of risk information throughout the supply chain42,43. However, some 
discussion of whether these and acceptance by all member states and globally 
harmonised version of these would be required (potential topic for globally harmonised 
system). 
• Occupational Exposure Limits (OELs) and Toxicological Reference Values 
(TRVs) 
Occupational Exposure Limits (OELs, for assessing occupational exposure) and 
Toxicological Reference Values (TRVs, for assessing exposure of the population) exist 
for very few NMs (like SiO2, TiO2). For chemically reactive nanoparticles, safety 
parameters (such as explosivity and flammability parameters) should also be provided. 
There is a strong need to translate the scientific data on hazards and especially toxicology 
into such values. Based on the available data on the toxicological properties of the NMs 
selected by project Scaffold, recommendations for occupational exposure limit values 
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 SECO. (2012). Safety data sheet (SDS): Guidelines for synthetic nanomaterials. Available at: 
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have been proposed for TiO2, SiO2, Carbon Nanofibers (CNF), Cellulose Nanofibers 
(CENF) and Nanoclays.44 Of course, the setting of limits, the routes of communicating 
with the organizations doing that, and the way how it is done have to be made transparent 
and need to be science based. 
 
2.3. Organisation/Inventory 
The challenge of managing safety is given to a certain extend to the regional, national 
and/or international nanosafety platforms in European countries. However, this is still 
done uncoordinated on European level, which shall be changed by recent activities (e.g. 
CSA NMBP-27-2016-project, etc.). A wide variety of national and (EU) regional 
platforms and centers can be observed which are dedicated to either research or 
dissemination of nanosafety. Broadly three categories can be distinguished: NanoSafety 
Research Centers, NanoSafety Expert Platforms, and NanoSafety Collaborations; 
2.3.1. NanoSafety Research Centers. Virtual stand-alone academic 
or collaborative entities between research institutes/ 
universities with focus on nanosafety research with national 
(e.g. governmental) funding. 
 Examples are the Finnish NanoSafety Research Centre45, the Danish Nano Safety 
Centre46, Namur NanoSafety Centre47, NanoSafety-Austria/EURO-NanoTox, etc. 
2.3.2. NanoSafety Expert Platforms: Collaboration on the level of 
(academic) experts, mainly focused on dissemination of 
nanosafety. Within the field of occupational safety and health, 
these platforms share knowledge, seek collaboration and 
provide scientific interpretation.  
 KIR nano (Risks of Nanotechnology Knowledge and Information Centre)48  
KIR nano was initiated by the Dutch government and is currently jointly 
sponsored by three Ministries. The target groups of KIR nano are staff at the 
ministries and other government organisations and EHS professionals. On a 
national level, KIR nano participates for instance in the interdepartmental 
working group on risks, in which various ministries are represented. 
 BioNanoNet Forschungsgesellschaft mbH49 
BioNanoNet is an Austrian Network that combines a wide range of expertise in 
numerous medical and pharmaceutical disciplines, with a strong focus on 
nanomedicine and nanotoxicology. BioNanoNet serves as the Austrian 
NanoSafety hub. The BioNanoNet GmbH has the clear aim of supporting 
innovative interdisciplinary research by forming cooperative networks and 
synergistic collaborations in order to initiate and coordinate national and 
international research projects. In addition to providing BioNanoNet’s nanosafety 
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expertise, the renowned BioNanoNet members include top-level scientists that 
work on several TRL’s to advance the safe implementation of nanotechnology. 
 SAFENANO50 
SAFENANO is dedicated to providing the highest quality expertise to help 
nanotechnology emerge and develop on a safe and sustainable basis, maximising 
its commercial potential, through a continuous development and improvement of 
our knowledge, equipment and practice. 
Vision: To be the leading multidisciplinary independent authority on nanosafety 
and partner of choice for industry and regulators, ensuring the safe and 
sustainable development of nanotechnology.  
Values: We develop and maintain valued relationships with our clients and 
stakeholders across the nanotechnology community. We uphold our independence 
and integrity. We set high standards of excellence both personally and 
professionally. 
 
2.3.3. NanoSafety Collaborations: Collaboration between academic 
experts/ institutes and industry 
 EHS - Advance51 
EHS-Advance is a Competence Centre distributed, promoted by the nanoBasque 
Agency, funded by the regional Basque Government (Spain) and currently under 
implementation phase by the technological centers GAIKER-IK452, TEKNIKER-
IK453 and the corporation TECNALIA54, within the framework of a Strategic 
Research project funded by the Basque Government. The initiative sets out to 
provide industry and other interested parties with service and support in the areas 
relating to the Environment, Health and Safety (EHS) whenever nanotechnologies 
are incorporated into its products and processes. The center seeks synergistic 
effects by merging capabilities of assessment, analysis and testing, and 
highlighting the existence of specific infrastructures in the Basque Country, with 
a strong relationship with organizations with the same interests at the European 
level thereby creating a One stop shop for nano EHS issues. The current offer 
includes: 1) Studies, analyses & tests (OECD, ASTM, ISO, CEN … in the areas 
of toxicology in vitro & in vivo, ecotoxicology), 2) Risk assessment & control, in 
processes (industrial safety & OHS), 3) Training, dissemination & awareness, 4) 
Development & implementation of methods and standards. 
 Nanocentre55 
Nanocentre is initiated by TNO in cooperation with RIVM and Syntens 
(Innovationplatform for SMEs) to support SMEs with safely innovation using 
NMs by providing tailored dissemination of knowledge on nanosafety and 
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innovation by nanotechnology or NMs. This information is provided by the 
website, where information can be retrieved, and where an interactive Q/A 
function, and a module for new questions can be accessed. In addition to the 
website, SMEs/ contact persons who signed up for the newsletter, are regularly 
invited for workshops with various topics related to safe use of NMs. Some of the 
workshops provide aspects of training/ instruction. 
Nanocentre partners use their own resources, however, both TNO and RIVM are 
indirectly supported by Government (i.e. the Ministries of Socials Affairs and 
Employment and Infrastructure and the Environment).  
 NanoHouse56 
The aim is to develop added value by initiating the application of nanotechnology 
within businesses. To realize this ambition, NanoHouse is the knowledge broker 
and project leader for businesses who are interested in applying nanotechnology. 
NanoHouse is interested in receiving worldwide information concerning: NMs 
functionalities, intermediate applications, and (international) research programs. 
The information will be freely distributed towards potential interested businesses 
to develop innovation projects and business clusters. 
NanoHouse is located in the South of the Netherlands and is working in parts of 
Belgium, the Netherlands and Germany. The reasoning is that many large and 
medium-sized companies and research institutes are located in this region and 
cooperation will be beneficial. NanoHouse consists of an advisory board, board 
and project office. 
 INERIS57 and CEA58, French institutes linking research and industry 
The French research and service institutes INERIS and CEA have developed an 
offer of services for the industry, from physico-chemical characterization and 
(eco)toxicology study to nanosafety at the workplace and integrated risk 
assessment, in the form of studies, training, and certification. 
 CRANN institute at Trinity College Dublin59 
CRANN (the Centre for Research on Adaptive Nanostructures and Nanodevices) 
is one of the largest research institutes in Trinity College Dublin and Ireland's 
leading nanoscience institute. 
CRANN brings together over 300 researchers including 37 leading Investigators 
based across multiple disciplines including Trinity's Schools of Physics, 
Chemistry, Medicine, Engineering and Pharmacology. The centre delivers 
internationally leading materials research that is industrially and clinically 
informed with outputs including new discoveries and devices in ICT, medical 
device and industrial technology sectors. The centre has a strong emphasis on 
linking industry to research programmes and the aim of the centre is to develop 
safe products that directly impact everyone’s quality of life such as the 
development of the next generation societal wellbeing. 
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 http://www.minatec.org/recherche/rd-interventions-sur-terrain 
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CRANN institute is supporting industry-academia research for industrial transfer 
(from low to mid-high TRL) with strong infrastructural and technical strengths in 
the areas of microscopy, computation and environmental health and safety 
assessment. On the latter, the group has built strong infrastructure and 
characterization know-how, which is enabled by strong collaboration at 
international level. 
 FENAC at the University of Birmingham60 
FENAC (Facility for Environmental Nanoscience Analysis and Characterisation) 
is a UK Natural Environment Research Council funded facility offering (funded) 
access to a suite of state of the art NMs synthesis, characterisation and impact 
assessment capabilities at expertise at the University of Birmingham. Access is 
provided on a the basis of peer-reviewed proposals for pilot projects or full 
investigations on all aspects of NMs interactions in living systems (with a focus 
on environmental aspects at present, although the remit is currently being 
expanded). A suite of additional services for SMEs, regulators and other 
stakeholders (e.g. water companies, city councils etc.) is currently being 
developed for launch in late 2016. A strong focus on characterisation of NMs in 
complex environmental and product matrices is a feature of FENAC’s expertise, 
with facilities for characterisation of interactions with biotic and abiotic matrix 
components. 
 
2.4. International cooperation 
Global cooperation is needed to along all nanosafety work. Some examples of 
international cooperation which are already dealing with nano-related topics are listed 
below. 
 Communities of Research61 
 A platform for scientists and other interested stakeholders from 
academia, government, industry, and NGOs in the US, EU, and 
beyond to develop a shared repertoire of protocols and methods to 
overcome research gaps and barriers and to enhance their professional 
relationships in the area of NMs safety assessment. 
 Latin America62 
 NMP-DeLA is a support action funded by the EU under FP7 for two 
years from 1st September 2013. It aims to facilitate the deployment of 
advanced and enabling technologies in areas of major social challenge 
in Latin America. The NMP-DeLA project brings together partners 
and experts from across Latin America and Europe to develop a series 
of activities between the two regions, to strengthen the local research 
and training potential, as means to achieve the goal of deployment of 
new, advanced and enabling technologies in areas of major social 
challenge in Latin America: water, energy and health. 
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 Australian Initiatives (NICNAS; ARC Centre of Excellence in Convergent Bio-Nano 
Science & Technology) 
 The National Industrial Chemicals Notification and Assessment 
Scheme (NICNAS) is a statutory scheme administered by the 
Australian Government Department of Health. NICNAS aids in the 
protection of the Australian people and the environment by identifying 
out the risks to occupational health and safety, to public health and to 
the environment that could be associated with the importation, 
manufacture or use of industrial chemicals, and by maintaining a 
national standard for cosmetic products. 
 The ARC Centre of Excellence in Convergent Bio-Nano Science and 
Technology is a national innovator in bio-nano sciences and an 
incubator of the expertise and technological excellence required to 
develop next generation bio-responsive NMs. 
 
• Needs Assessment  
The development (and consolidation) of a suite of NanoSafety Services into a European 
one stop shop will reduce the uncertainties, increase the confidence in this technology, 
and will lead to acceptance of nano-enabled products.  
The needs of the various concerned stakeholders have to be further elaborated within 
future activities (e.g. consultation rounds, polls, interviews, etc.); comments of initial 
analysis are outlined below: 
 Industry and market view 
Nanotechnology is making advances faster than the safety management related to it. 
Development of new methods, strategies and tools for risk management based on 
solid scientific knowledge may take a longer time than their market presence. 
European industry is already manufacturing NMs and nano-enabled products and 
workers might be exposed to nanomaterials. Consequently, efforts should be made to 
provide the industry with intermediate management solutions, based on the state of 
the art, to make decisions with minimal uncertainties. This would mean the need to 
translate and encapsulate the results of current research into a battery of practical 
methods, strategies and tools for the management of nano-risks, directly usable by 
industry and companies that provide services to industry. 
In addition, there is a need to establish adequate strategies to manage and 
communicate risks of NMs and nano-enabled products further down the supply chain, 
to both professional and consumer users of the product(s), where appropriate. There 
are already a couple of interesting sources of information like the “Nanorama 
Laboratory”, an online, interactive tool to help laboratory personnel understand how 
to safely handle nanomaterials 63. Collecting, evaluating and presenting of up-to-date 
scientific facts in an easy comprehensible way is the main focus of the project DaNa 
2.0.64 A scientific expert team prepared the latest research findings from the field of 
human and environmental nanotoxicology and present these together with material 
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 http://nano.dguv.de/nanorama/bgrci/en/ 
64
 http://www.nanopartikel.info/en/projects/current-projects/dana-2-0 
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properties and possible applications for interested laymen, stakeholders and other 
scientists. These data and together with further facts on nanotechnology are publicly 
available on the internet platform “Nanoobjects”.65 
Industry is not only responsible for ensuring the quality and safety of the product it 
produces, but also has a corporate responsibility to communicate information 
regarding risks downstream workers / consumers may be exposed to. 
Communicating with consumers about well understood risks can help to provide 
assurance that such risks are being actively managed, improving the acceptance of 
nanotechnology by end-users. Work with consumer agencies (e.g. Which? in the UK) 
could be facilitated to allow direct comparison of products with/without NMs (e.g. 
sunscreen) such that the real benefits to consumers are demonstrated clearly and in an 
unbiased manner. Such activities could be built into the stakeholder engagement 
activities of an EU NanoSafety Centre. 
 Science view 
From the scientific perspective there has been an accelerated evolution and in depth 
knowledge generated around nanosafety across the many research projects and 
flagship initiatives, which have been funded towards the creation of good reliable 
data, safety-by-design approaches, decision-making processes, safety value chain and 
methodologies for assessing safety from in vitro and in silico models to worker 
protection and environmental safety. Development of experimental and 
computational methodologies, characterization and standardisation are at the basis of 
the scientific data to be provided for the assessment of MNMs. 
The next critical phase is the consolidation of this knowledge, in order to re-assess 
which of the previous knowledge-gaps have now been filled, where established and 
validated protocols exist and should be utilised as standard, and where research effort 
should now focus (e.g. on testing of appropriately aged NMs, on longer term 
exposures / chronic studies, on more realistic in vitro models that are predictive of in 
vivo effects, etc.). EU FP7 project NanoMILE (www.nanomile.eu) is taking an 
initiative in this direction to develop consensus reports on several key aspects of 
nanosafety during 2016, including methods for NMs characterisation in complex 
matrices (with NanoValid and MARINA), high throughput and omics methods (with 
NanoSolutions) and on environmental assessment (with GuideNano and NanoFASE), 
based on NANoREG-project’s output. These consensus papers will facilitate contract 
research organisations and regulatory authorities to converge on agreed test methods 
for regulatory dossiers, and facilitate contract research organisations to take over the 
assays and SOPs and deliver them as services for enterprise and SMEs. 
 Further views 
In addition to the above highlighted views, it would be of utmost importance to 
consider the governmental view in several states in Europe, which will enable 
regional differences in perception, engagement, and structuring to be taken into 
account. Key to a common approach in Europe will be the integration of national 
stakeholders points of view with the tasks and needs on European level from EC, and 
the translation of guides for SMEs and others into all EU languages. Hence, a 
coordinated structure which enables taking into account lessons learned from the 
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past, combining this with new aspects recommended in this roadmap, the 
inclusiveness throughout all European countries as well as with global players will 
ensure to gain acceptance in all communities. 
• Timeline for further needs assessment 
Mid 2016 – implementation of existing strategies and consolidation of resources 
Mid 2016 – start preparation of Research- and CSA-topics for the future calls, addressing 
the identified bottlenecks. 
2017 – next call for proposals addressing “CTTM”-roadmap- actions 
2018 – start development of CTTM-call topics looking at the needs from 2020-2030 
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2.5. Current bottle-necks (hindering large scale access to the market of MNMs) 
2.5.1. Occupational safety: sustainable marketing requires that 
employees and employers are confident in the safety of the 
processes implemented for their protection: 
Please note: the Bottle-necks are NOT ordered by any means; if needed, they could be 
prioritised in a next step. 
Bottle-neck Solutions Layer(s) concerned 
Lack of awareness of employees 
and employers 
• Operational OSH solutions  
• Communication / training 
• Application of a diligent and 
precautionary approach to 
labelling  
• Proper SDSes 
1. Scientific knowledge 
3. CTTM 
Uncertainty in efficiency of 
prevention/protection measures  
• Improve knowledge 
• Develop adequate portable 
(personal) measuring equipment, 
including SOPs 
• Develop safer processes anyway 
(e.g. less release during 
production, fire/explosion, 
massive release  protection 
systems) 
• Standardized protocols to support 
the evaluation of the 
effectiveness of common RMMs 
1. Scientific knowledge 
3. CTTM 
 
Uncertainties in risk assessment 
and in regulation 
• Improve and stabilize the 
regulation 
• communicate uncertainties 
2. Regulatory research 
3. CTTM 
Lack of validated reference 
control banding tools 
• Operational OSH solutions  
• Standardisation 
1. Scientific knowledge 
3. CTTM 
Lack of validated methods 
(toxicological and analytical) for 
nanosafety assessment 
• Equipment 
• Harmonization 
• Round robins 
• validation studies 
• General guidelines how to 
standardise nano-specific 
protocols 
1. Scientific knowledge 
3. CTTM 
 
Lack of Occupational Exposure 
Limits (OELs) and safety 
parameters for reactive NMs 
(explosion/fire, runaway 
reactions) 
• Transcription from scientific 
knowledge and OSH expertise to 
Occupational Exposure Limits 
and reaction safety Limits; link 
with SCOEL. 
• Harmonization, validation, 
Standardisation of protocols to 
1. Scientific knowledge 
2. Regulatory research 
3. CTTM 
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measure the levels of exposure in 
the workplace. 
• Personal measuring equipment 
Lack of transmission of 
nanosafety information through 
the Safety Data sheets 
• Transcription processes from 
scientific knowledge to the SDS 
• Development of high quality 
SDS reflecting as best as possible 
current knowledge in the field 
2. Regulatory research 
3. CTTM 
Lack of nanosafety management 
systems 
Lack of integration of 
nanosafety issues into industry 
process management systems. 
• (sector specific) nanosafety 
management systems, propor-
tional to the respective situation 
• Standardisation, training and 
certification 
• Translate and encapsulate the 
results of research in a battery of 
practical methods, strategies and 
tools for the management of 
nano-risks 
• Harmonized standards 
1. Scientific knowledge 
3. CTTM 
 
Lack of support for the 
implementation of the previous 
items 
• Helpdesk, Q&A platforms 
• Translation into EU languages 
• Collaboration with sector-
specific industry associations and 
trade unions 
3. CTTM 
Lack of trust towards employers 
in the field of Nano-OSH 
• Open two-way communication 
with open results 
• OHS Training for nano-workers 
in addition to companies working 
with nano (including online) to 
inform workers of their rights 
and responsibilities. 
• Voluntary Nano-exposure 
registries whereby workers 
handling NMs can volunteer for 
periodic health checks as a means 
to initiate long-term exposure 
monitoring and epidemiological 
studies. 66 
1. Scientific knowledge 
3. CTTM 
Lack of regulation specifying 
requirements to ensure the safety 
and health of workers exposed to 
nano-risks (the game board) 
• New or improved regulation 
• Harmonized standards  
2. Regulatory research 
3. CTTM 
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 Michaela Kendall, Iseult Lynch, (2016), Long Term Monitoring for Nanomedicine Implants and Drugs, 
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2.5.2. Public safety: sustainable marketing requires that consumers 
are confident in the safety of the products they purchase: 
Bottle-neck Solutions Layer(s) concerned 
Improve the trust towards 
regulation (REACH: adapted 
to nanos?)  
• Follow and communicate safety 
and labelling rules. These laws 
and their related regulations are 
intended to protect consumers 
from health hazards and 
deceptive practices and to help 
consumers make informed 
decisions regarding product 
purchase. 
• Integrate latest knowledge into 
regulation (e.g. if/if not labelling, 
clear definitions and tools to 
measure, etc.) 
• Open two-way communication 
with open sharing of results 
• Promotion of REACH 
implementation as a key action in 
nanosafety projects 
2. Regulatory research  
3. CTTM 
Lack of Toxicological 
Reference Values (TRVs) 
 
• Transcription from scientific 
knowledge and risk assessment 
expertise to Toxicological 
Reference Values 
1. Scientific knowledge 
3. CTTM 
Improve trust towards 
employers in the field of 
Nano-OSH 
• Open two-way communication  3. CTTM 
Lack of Risk characterization 
awareness 
• Open two-way communication 
sharing of outcomes even where 
unfavourable towards use of 
nanotechnologies 
• Cooperation with consumer 
organisations (e.g. Which?) to 
assess nano/non-nano products 
and communicate the results 
openly. If benefits are for the 
company (e.g. improved process) 
or the environment (for example) 
rather than consumer, need to be 
open about this and allow 
consumer freedom of choice; e.g. 
using LCA-approach. 
3. CTTM 
Lack of Risk characterization 
awareness 
• Open two-way communication 
with open sharing of results 
• Option for consumers also to 
participate in voluntary exposure 
and health monitoring 
3. CTTM 
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programmes? This could also be 
linked to food, cosmetics and 
nanomedicines, and could 
operate as an important 
assessment of impacts of 
cumulative exposures to different 
NMs from different products, 
which is an area we genuinely 
know very little about at present. 
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2.6. Actions proposed/CTTM-future topics 
For the identified bottle-necks proposals for actions to be taken are shown in this chapter. 
The identifier shows the abbreviation for this roadmap CTTM, a numbering and suggests 
a timeline to implement the action (st = short term 2018-2020; lt = long term 2020 and 
beyond). 
CTTM 01 st  
Occupational 
Safety 
Objective 
Employees and employers are confident in the safety of the processes 
implemented for their protection 
Current challenges Activities  Timeline 
Lack of awareness of 
employees and 
employers 
• Networking 
 Interaction and adequate communication 
between existing platforms (e.g; NanoSafety 
cluster) and industry/SMEs/trade unions to 
raise awareness 
 Development of an European nano-network 
 Networks should be open for all stakeholders 
• Reporting 
 Reporting of studies, guidelines etc can 
provide sufficient and useful information, 
after performing a mandatory quality check 
• Communication 
 Successful communication and outreach, in 
order to ensure safety and consolidate the 
trust and the confidence required 
 Interaction and adequate, unbiased, targeted 
and reliable communication/networking in 
order to promote the application of up-to-
date safety culture 
• Standardization 
 Establish a “universal” definition of key terms 
(i.e. nanomaterials) including means to 
measure 
• Assistance to new-comers 
 Scientific inclusiveness and information 
sharing within the nano-network approach  
• Assistance to regulators 
 Training of persons which are involved in 
regulation or risk assessment (e.g.; ECHA 
initiatives such as their science meetings, and 
recent activities around e.g. omics) 
Professional training and certification 
 Development of first initiatives so as to make 
available to industry and other stakeholders 
concerned a global, up-to-date, science-
based, complete training and certification 
system for nanosafety. This should be for 
employers / OSH managers, but also for 
employees handling NMs in order that they 
have full understanding of potential risks and 
their rights and responsibilities.   
Short term  
Uncertainty in efficiency 
of prevention/protection 
• Networking 
 Networking of existing platforms, including 
the NanoSafety cluster, at European level 
Short term  
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measures and cooperation with third countries to 
improve knowledge 
• Benchmarking 
 Assess and increase safety in regulatory 
terms, and the capacity to develop and 
implement safety-by-design processes and 
products with the aim of keeping safety level 
above pre-defined values 
• Data Collection 
 Data generation based on harmonized and 
standardized protocols should precede ‘raw’ 
data collection to ensure that scientifically 
solid data are collated (e.g.; eNanoMapper 
project, Exposure Scenario library and the 
Exposure Efficacy Control Library, NANoREG 
database) 
• Reporting 
 Reporting of studies, guidelines etc can 
provide sufficient and useful information 
• Communication 
 Successful communication and outreach, in 
order to ensure safety and consolidate the 
trust and the confidence required 
• Standardization 
 Development of harmonized, validated 
methods, which ideally are generally (i.e. 
internationally) accepted (preferable OECD, 
ISO, CEN) 
Uncertainties in risk 
assessment and in 
regulation 
• Networking 
 Networking of existing platforms, including 
the NanoSafety cluster, at European level 
and cooperation with third countries to 
improve knowledge 
• Communication 
 Interaction and adequate, unbiased, targeted 
and reliable communication/networking in 
order to eliminate uncertainties in risk 
assessment and in regulation 
• Assistance to new-comers 
 Development of guidelines and best 
practices guide for the safe handling and use 
of NMs in different sectors; as well as new 
tools to support the implementation of 
relevant pieces of regulation, including 
REACH regulation 
• Feedback for agreeing next research 
priorities 
 Involvement of highly renowned actors in the 
research and industrial field and the 
interaction with several stakeholders (e.g. 
European as well as global active bodies in 
standardization, regulation, etc.) to 
determine and agree future research 
priorities  
• Professional training and certification 
 Training of persons which are involved in 
regulation or risk assessment (e.g.; ECHA 
Short term 
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initiatives such as their science meetings, and 
recent activities around omics and HCA)   
Lack of trust towards 
employers in the field of 
Nano-OSH 
• Communication 
 Successful communication and outreach, 
in order to ensure safety and 
consolidate the trust and the confidence 
required 
• Assistance to new-comers 
 OHS Training for nano-workers in 
addition to nano-active companies to 
inform workers of their rights and 
responsibilities 
• Professional training and certification 
 Training of workers would also help 
to reduce mis-trust of their 
employers  
 Establish epidemiological studies and 
monitoring (e.g.; voluntary EU-wide 
monitoring of exposure and health 
over the long term)  
Short term 
   
CTTM 02 st - lt 
Occupational 
Safety 
Objective 
Validated, standardized safety tools are available. 
Current challenges Activities  Timeline 
Lack of validated 
reference control banding 
tools 
• Standardization 
 Harmonized, standardized and validated 
control banding tools based on state-of-the-
art safety management should be available 
for OSH consultants and managers 
Long term 
Lack of validated 
methods (toxicological 
and analytical) for 
nanosafety assessment 
• Standardization 
 General guidelines how to standardise 
nano-specific protocols 
 Development of harmonized, validated 
methods, which ideally are generally (i.e. 
internationally) accepted 
 Standardization workshop with 
competent experts  
 Harmonization of protocols and inter-lab 
training 
 Round Robins, involving external labs 
e.g. standard metrology labs 
short term 
Lack of Occupational 
Exposure Limits (OELs) 
and safety parameters for 
reactive NMs 
(explosion/fire, runaway 
reactions) 
• Standardization 
 Implementation of valid globally 
harmonized Occupational Exposure 
Limits (OELs), as well as reactivity 
parameters (explosion & flammability 
limits) e.g.; via transcription from 
scientific knowledge and OSH expertise 
to Occupational Exposure Limits and 
reaction safety Limits 
Short term 
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Lack of transmission of 
nanosafety information 
through the Safety Data 
sheets 
• Reporting/Standardization 
 Development of “nano SDS” i.e.; SDS 
which includes hazard and risk phrases, 
detailed information about the product 
composition and their possible nano-
specific health and safety issues  
Long term 
Lack of nanosafety 
management systems 
Lack of integration of 
nanosafety issues into 
industry process 
management systems 
• Reporting/Networking 
 Development, testing, validation and 
dissemination of holistic, consistent and 
cost effective RMM 
• Certification of methods 
 Transferability of RMM methods need to 
be demonstrated in a second stage, 
typically be performing round robin 
exercises 
Short term 
Lack of support for the 
implementation of the 
previous items 
• Networking 
 Interaction and adequate communication 
between existing platforms (e.g; NanoSafety 
cluster) and industry/SMEs to raise 
awareness 
• Communication 
 Successful communication and outreach, in 
order to ensure safety and consolidate the 
trust and the confidence required 
 Interaction and adequate, unbiased, targeted 
and reliable communication/networking in 
order to promote the application of up-to-
date safety culture 
Long term 
Lack of regulation 
specifying requirements 
to ensure the safety and 
health of workers 
exposed to nano-risks 
(the game board) 
• Networking 
 Networking of existing platforms, including 
the NanoSafety cluster, at European level 
and cooperation with third countries to 
improve knowledge 
• Communication 
 Interaction and adequate, unbiased, targeted 
and reliable communication/networking in 
order to eliminate uncertainties in risk 
assessment and in regulation 
 provide an overview on which guidance 
documents already exist and link them such 
that market actors 
• Assistance to new-comers 
 Development of guidelines and best 
practices guide for the safe handling and use 
of NMs in different sectors; as well as new 
tools to support the implementation of 
relevant pieces of regulation, including 
REACH regulation 
• Feedback for agreeing next research 
priorities 
 Involvement of highly renowned actors in the 
research and industrial field and the 
interaction with several stakeholders (e.g. 
European as well as global active bodies in 
standardization, regulation, etc.) to 
determine and agree future research 
priorities  
Long term 
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• Professional training and certification 
 Training of persons which are involved in 
regulation or risk assessment (e.g.; ECHA 
initiatives such as their science meetings, and 
recent activities around omics and HCA)  
 
CTTM 03 st-lt 
Public Safety 
Objective 
Consumers are confident in the safety of the products they purchase 
Current challenges Activities Impact Timeline 
Improve the trust 
towards regulation 
(REACH: adapted to 
nano?)  
• Integration of latest knowledge 
into regulation 
• Promotion of REACH 
implementation as a key action 
 Supply a translation which 
suits the consumers’ needs 
• Communication 
 Open two-way communication 
with open sharing of results  
 Science-based cooperation 
between stakeholders 
 Unbiased, targeted and 
reliable communication 
• Networking at global level 
Assistance to 
regulators, 
special training 
for persons 
involved in 
regulation  
Long term 
Lack of Toxicological 
Reference Values 
(TRVs) 
 
• Transcription from scientific 
knowledge and RA expertise to 
Toxicological Reference Values 
(TRVs) 
Realization of 
science-based 
human risk 
assessment for 
risk-based 
management 
Short 
term 
Improve trust 
towards employers 
in the field of Nano-
OSH 
• Communication 
 Open two-way communication 
with open sharing of results  
Professional 
training and 
certifications 
 
Short 
term 
Lack of Risk 
characterization 
awareness 
• Communication 
 Open two-way communication 
with open sharing of results 
• Cooperation with consumer 
organisations to assess 
nano/non-nano products and 
communicate the results 
openly 
• Option for consumers also to 
participate in voluntary 
exposure and health 
monitoring programmes 
Reliably 
informed 
unbiased 
consumers,  
Freedom of 
choice for 
consumers 
Long term 
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2.7. Expected outcome 
2.7.1. Guidance to market actors (industry, public authorities) 
Currently guidance documents are established from various regulatory panels and other 
stakeholders. For instance the EU Scientific Committee on Consumer Safety (SCCS) has 
published a document (SCCS/1524/13)67, which addresses the relevance, adequacy and 
quality of data in safety dossiers of NM in cosmetics. The European Chemicals Agency 
(ECHA) has published outcomes from expert meetings on best practices on 
physicochemical and substance identity information for NMs68, on best practices for 
REACH registrants on assessing human health and environmental hazards for NM69 as 
well as guidance on human health and environmental exposure assessment and risk 
characterization of NM70. EFSA published a guidance document for risk assessment of 
NM in food and feed71. Also at the OECD level various guidance documents are 
developed such as the guidance document on sample preparation and dosimetry72. Finally 
SCENHIR has published a guidance document for risk assessment of nanomaterials73. 
However, regulation is differently organized in various sectors, i.e. different regulations 
applies in e.g. cosmetics, food, biocides, and chemicals. Therefore, as a first tier it may 
be highly useful to provide an overview on which guidance documents already exist and 
link them such that market actors, in particular SME, can have easy access. In the second 
tier, it may furthermore be highly useful to have a closer look into these guidance 
documents. Several of them are rather unspecific. Some of them also include a 
compilation of research needs, rather than giving specific guidance. Therefore in a 
second tier, the information currently contained in already existing guidance documents 
could be extracted and summarized as a set of specific actions SMEs should undertake. 
                                                 
67 Scientific Committee on Consumer Safety (SCCS), (2014), Memorandum on Relevance, Adequacy and 
Quality of Data in Safety Dossiers on Nanomaterials; 
http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_142.pdf 
68 European Chemical Agency (ECHA), (2013), Best practices on physicochemical and substance identity 
information for nanomaterials; 
http://echa.europa.eu/documents/10162/5399565/best_practices_physiochem_subst_id_nano_en.pdf 
69 European Chemical Agency (ECHA), (2013), Assessing human health and environmental hazards of 
nanomaterials - Best practice for REACH Registrants; 
http://echa.europa.eu/documents/10162/5399565/best_practices_human_health_environment_nano_en
.pdf 
70
 European Chemical Agency (ECHA), (2013), Guidance on human health and environmental exposure 
assessment and risk characterization of NM - Best practice for REACH registrants; 
http://echa.europa.eu/documents/10162/5399565/best_practices_human_health_environment_nano_3r
d_en.pdf 
71
 European Food Safety Authority (EFSA), (2011), EFSA published a guidance document for risk 
assessment of NM in food and feed, EFSA Journal 9(5):2140 [36 pp.]; DOI: 10.2903/j.efsa.2011.2140 
72
 OECD, (2012), Guidance on Sample Preparation and Dosimetry for the Safety Testing of Manufactured 
Nanomaterials - Series on the Safety of Manufactured Nanomaterials No. 36; 
http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2012)40&docl
anguage=en 
73
 Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), (2009), Risk 
Assessment of Products of Nanotechnologies; 
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Finally, in a third tier, more specific guidance documents e.g. for each sector could be 
established, again in close collaboration with sector-specific industry associations, which 
specifically do address also technical issues and give methodological details (e.g. how to 
measure a certain group of NM in a given matrix). The third tier may require additional 
method establishment or validation and thus is dependent on close interactions to other 
points already mentioned in this document. Aligning such activities via a specific 
research infrastructure dedicated to support and enable NMs regulation could facilitate 
such activities via the Joint Research Activities. 
2.7.2. Best practice 
To be elaborated within future projects, but directed via the ongoing gap analysis 
identified in the CTTM roadmap and resulting activities. 
Specific examples that could be addressed in the medium term include support for SMEs 
in determining the “sameness” of their NMs/nano-enabled products to already approved 
substances / articles. This could be via a service provision, funded for example, via an 
EU infrastructure project. 
2.7.3. Standards, technical approvals 
To be elaborated within future projects but directed via the ongoing gap analysis 
identified in the CTTM roadmap and facilitated via the specific activities identified 
above where the CTTM implementation via a CSA or research infrastructure around 
standardisation, such as supporting projects in writing their standardisation section 
(including the steps required, their timing and costings), as well as consolidation with 
ongoing activities and support in identifying the experts needed. 
2.7.4. Environmental protection 
To be elaborated within future projects but directed via the ongoing gap analysis 
identified in the CTTM roadmap and aligned with the industry employer needs identified 
in the FP7 NanoEIS educational needs analysis which highlighted a lack of training / 
expertise in end of life cycle, environmental assessment and waste management tools. 
2.7.5. Operational certification systems 
To be elaborated within future projects but directed via the ongoing gap analysis 
identified in the CTTM roadmap, aligned with developments in the regulatory landscape 
(and the regulatory roadmap) and building on existing offerings such as that from 
INERIS/CEA. 
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2.7.6 Epidemiological studies 
A key opportunity identified in this CTTM roadmap is the potential for utilising the 
above-mentioned training and certification systems as a means to identify cohorts or 
workers potentially exposed to NMs and recruit such individuals/organisations for long-
term exposure and health monitoring. This could be funded at the individual member-
stage level (via an ERA) or more effectively via a research infrastructure project (with a 
longer-term follow-up funding solution found beyond that) to facilitate longitudinal data 
collection. This needs to be done anyway, and linking it to the CTTM roadmap and 
activities seems like an optimal way to ensure buy-in and cooperation of all relevant 
stakeholders in the nano arena. 
 
2.8. Impact 
Following the recommendations of the CTTM, the European Nano-EHS-ecosystem will 
enable the long-term success of nanotechnologies on the market. Gaining trust via 
working transparently and cooperating with global players, will ensure acceptance of the 
CTTM-actions across all sectors involved. However, the cooperation has to clearly focus 
on market-support oriented stakeholders and definitely not on “creating a risk-market” 
activities. On route to the development of the CTTM-roadmap it became clear, that this 
exercise only gains the expected impact, if the so-called key-players are integrated into 
this work fully. 
According to the identified key challenges, already the first action of building an 
inclusive collaboration network which has to include and be supported by a huge number 
of international states will ensure high impact because it is not a “pre-selected closed 
group” but an open inclusive team or nanosafety community. In addition to this, the 
bringing together of the scientific experts of each country further boosts the impact of 
this activity and will indeed be beneficial for all involved countries and their market 
players. The proposed actions in chapter 2.6 will create value-added via strengthening the 
dialogue and interaction to raise synergies and provide safety-assessment resources and 
best practices from across Europe for researchers, regulators and industry. This will also 
reduce the timespan from idea to the market especially by accompanying activities to 
support the development of products and applications via sharing of existing knowledge, 
route to market experience, and indeed learning from past failures. 
Very high potential can be expected also during the implementation of the safety 
assessment framework (supported by the regulatory initiatives), which may start via 
building service provider platforms (e.g. one in each country strongly connected with the 
central node) which deal as consulting agencies on their products, and facilitating and 
advising on its way towards market implementation. Via these actions, the market share 
of safety-assured nano-enabled products and applications will tremendously increase 
which shows the high value of the implementation of the CTTM recommendations. 
General impact of the research priorities 
• The improvement of efficacy of toxicology studies of nanomaterials and 
certification of methods 
• To provide industrial stakeholders and the general public with appropriate 
knowledge on the risks of nanoparticles and NMs for human health and the 
environment. 
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• The establishment of an ongoing dialogue between all stakeholders to 
additionally overcome the existing lack of knowledge transfer in the economic 
and societal point of view. 
• The value chain from Idea to Market (and beyond) very much depends on 
research management (lower TRLs), Pilot technology and Industrial scale-up 
management (middle TRLs) and innovation and commercialisation management 
(higher TRLs). The implementation of CTTM-topics will enable that earlier 
building of “Business Plan(s)” of any product supports the better and the faster 
movement towards the market. Hence, the earlier we integrate in the “Business 
Plan” the nanosafety dimension, the faster and better the safety requirements can 
be taken into account at each TRL level and permit industry to “internalise” in 
their plans the safety issues, the bankability of safety can be increased and 
become part of the “market asset” of the product. 
 
2.9. Timeline and next steps 
First step is underway by a coordination and support action bringing together nanosafety 
management platforms and institutes of the member states, in which they have invested 
to build, staff and operate. Furthermore, joint calls will be implemented to pool national 
funding from member states and third countries (e.g. USA) to finance Nano-EHS-
Research and market-oriented accompanying measures which are of common interest for 
the platforms the timeline is to get the action operational end 2016. The aim is to use this 
CSA to develop further actions. 
The platforms provide services and support for stakeholders (e.g. industry, governments, 
researchers etc.) to create in a sustainable way marketable, societal approved products 
and goods.  
The CTTM will be part of the NanoSafety Cluster strategic research and innovation 
agenda which shall be launched end of 2016. 
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